CLOPIDOGREL ZENTIVA 75 mg, film-coated tablet 30 tablets, CIP 3400938806397
Active ingredients: Clopidogrel bisulfate, Clopidogrel
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400938806397orale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- CLOPIDOGREL ZENTIVA 75 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA (REPUBLIQUE TCHEQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68519902CIP73880639CIP133400938806397Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLOPIDOGREL (HYDROGÉNOSULFATE DE)comprimé | — | SA |
| CLOPIDOGREL BASEcomprimé | 75 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.